Affymax, (FRA:A5Y) Dividends per Share : €0.00 (TTM As of Jun. 2014)

View and export this data going back to . Start your Free Trial

What is Affymax, Dividends per Share?

Affymax,'s dividends per share for the three months ended in Jun. 2014 was €0.00. Its dividends per share for the trailing twelve months (TTM) ended in Jun. 2014 was €0.00. Its Dividend Payout Ratio for the three months ended in Jun. 2014 was 0.00. As of today, Affymax,'s Dividend Yield % is 0.00%.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average dividends per share growth rate.

For more information regarding to dividend, please check our Dividend Page.

Affymax, Dividends per Share Historical Data

The historical data trend for Affymax,'s Dividends per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affymax, Dividends per Share Chart

Affymax, Annual Data

Trend

Dec04

Dec05

Dec06

Dec07

Dec08

Dec09

Dec10

Dec11

Dec12

Dec13

Dividends per Share

Get a 7-Day Free Trial

Affymax, Quarterly Data
	Sep09	Dec09	Mar10	Jun10	Sep10	Dec10	Mar11	Jun11	Sep11	Dec11	Mar12	Jun12	Sep12	Dec12	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14
Dividends per Share	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of Affymax,'s Dividends per Share

For the Biotechnology subindustry, Affymax,'s Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Affymax,'s Dividend Yield % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Affymax,'s Dividend Yield % distribution charts can be found below:

* The bar in red indicates where Affymax,'s Dividend Yield % falls into.

Affymax, Dividends per Share Calculation

Dividends paid to per common share.

Affymax, (FRA:A5Y) Dividends per Share Explanation

1. Dividend Payout Ratio measures the percentage of the company's earnings paid out as dividends.

Affymax,'s Dividend Payout Ratio for the quarter that ended in Jun. 2014 is calculated as

Dividend Payout Ratio	=	Dividends per Share (Q: Jun. 2014 )	/	EPS without NRI (Q: Jun. 2014 )
	=	0	/	0
	=	N/A

2. Dividend Yield % measures how much a company pays out in dividends each year relative to its share price.

Affymax, Dividends per Share Related Terms

Thank you for viewing the detailed overview of Affymax,'s Dividends per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Affymax, (FRA:A5Y) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Affymax, Inc. (FRA:A5Y) » Definitions » Dividends per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

630 Fifth Avenue, 2nd Floor, New York, NY, USA, 10020

Website

http://www.affymax.com

Affymax Inc is a development-stage biopharmaceutical company, engaged in developing novel peptide-based therapeutics for the treatment of life-threatening conditions. The company's product includes OMONTYS, an injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis. OMONTYS is a synthetic, peptide-based erythropoiesis stimulating agent, or ESA, designed to stimulate the production of red blood cells and has been the only once-monthly ESA available to the adult dialysis patient population in the U.S.

Affymax, (FRA:A5Y) Headlines

No Headlines